DK3020732T3 - Immunoglobulin-Fc-konjugat, som bevarer immunoglobulin-Fc-fragmentets bindingsaffinitet til FcRn - Google Patents
Immunoglobulin-Fc-konjugat, som bevarer immunoglobulin-Fc-fragmentets bindingsaffinitet til FcRn Download PDFInfo
- Publication number
- DK3020732T3 DK3020732T3 DK14822721.8T DK14822721T DK3020732T3 DK 3020732 T3 DK3020732 T3 DK 3020732T3 DK 14822721 T DK14822721 T DK 14822721T DK 3020732 T3 DK3020732 T3 DK 3020732T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunoglobulin
- fcrn
- conjugate
- retains
- fragment
- Prior art date
Links
- 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 title 1
- 101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 title 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 title 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20130082509 | 2013-07-12 | ||
| PCT/KR2014/006328 WO2015005747A1 (ko) | 2013-07-12 | 2014-07-14 | FcRn 결합력이 유지되는 면역글로불린 Fc 결합체 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3020732T3 true DK3020732T3 (da) | 2020-06-15 |
Family
ID=52280325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14822721.8T DK3020732T3 (da) | 2013-07-12 | 2014-07-14 | Immunoglobulin-Fc-konjugat, som bevarer immunoglobulin-Fc-fragmentets bindingsaffinitet til FcRn |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20160152684A1 (da) |
| EP (1) | EP3020732B1 (da) |
| JP (2) | JP2016525099A (da) |
| KR (2) | KR101872559B1 (da) |
| CN (2) | CN116082528A (da) |
| AR (1) | AR096890A1 (da) |
| AU (1) | AU2014287879B2 (da) |
| CA (1) | CA2917838C (da) |
| DK (1) | DK3020732T3 (da) |
| EA (1) | EA034297B1 (da) |
| ES (1) | ES2799326T3 (da) |
| HK (1) | HK1221957A1 (da) |
| HU (1) | HU231424B1 (da) |
| IL (1) | IL243567B (da) |
| MX (1) | MX2016000344A (da) |
| MY (1) | MY180374A (da) |
| NO (1) | NO20160182A1 (da) |
| PH (1) | PH12016500111A1 (da) |
| PT (1) | PT3020732T (da) |
| TW (1) | TWI693236B (da) |
| UA (1) | UA119644C2 (da) |
| WO (1) | WO2015005747A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130049671A (ko) | 2011-11-04 | 2013-05-14 | 한미사이언스 주식회사 | 생리활성 폴리펩타이드 결합체 제조 방법 |
| AR090281A1 (es) | 2012-03-08 | 2014-10-29 | Hanmi Science Co Ltd | Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo |
| CN117065044A (zh) * | 2014-03-31 | 2023-11-17 | 韩美药品株式会社 | 通过使用免疫球蛋白Fc片段连接改善蛋白质和肽的溶解度的方法 |
| AR107483A1 (es) | 2016-01-29 | 2018-05-02 | Hanmi Pharm Ind Co Ltd | Conjugado de enzimas terapéuticas |
| WO2018117613A1 (ko) * | 2016-12-19 | 2018-06-28 | 한미약품 주식회사 | 뇌 표적 지속성 단백질 결합체 |
| US20220273808A1 (en) * | 2019-07-18 | 2022-09-01 | Hanmi Pharm. Co., Ltd | Novel method of preparing protein conjugate |
| KR102382593B1 (ko) * | 2020-01-29 | 2022-04-05 | 고려대학교 산학협력단 | pH-감응성 Fc 변이체 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6030613A (en) * | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| WO1997034631A1 (en) | 1996-03-18 | 1997-09-25 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| UA90654C2 (ru) * | 2002-12-26 | 2010-05-25 | Маунтин Вью Фармасьютикалз, Инк. | Полимерные конъюгаты интерферона-бета с повышенной биологической активностью |
| US20050176108A1 (en) * | 2003-03-13 | 2005-08-11 | Young-Min Kim | Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| AU2004282984B2 (en) * | 2003-11-13 | 2011-07-14 | Hanmi Science Co., Ltd. | Protein complex using immunoglobulin fragment andmethod for the preparation thereof |
| KR100609434B1 (ko) | 2004-12-30 | 2006-08-03 | 한국항공우주연구원 | 트랜스버살 필터 |
| KR100754667B1 (ko) * | 2005-04-08 | 2007-09-03 | 한미약품 주식회사 | 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물 |
| US7625564B2 (en) * | 2006-01-27 | 2009-12-01 | Novagen Holding Corporation | Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| JP2008169195A (ja) * | 2007-01-05 | 2008-07-24 | Hanmi Pharmaceutical Co Ltd | キャリア物質を用いたインスリン分泌ペプチド薬物結合体 |
| KR20080098216A (ko) * | 2007-05-04 | 2008-11-07 | 한미약품 주식회사 | 캐리어 물질을 이용한 나트륨 배설 펩타이드 약물 결합체 |
| JP5577243B2 (ja) * | 2007-05-30 | 2014-08-20 | ポステク アカデミー−インダストリー ファウンデイション | 免疫グロブリン融合タンパク質 |
| JP2009019027A (ja) | 2007-07-16 | 2009-01-29 | Hanmi Pharmaceutical Co Ltd | アミノ末端のアミノ酸が変異したインスリン分泌ペプチド誘導体 |
| MY151184A (en) * | 2008-07-23 | 2014-04-30 | Hanmi Science Co Ltd | A polypeptide complex comprising non-peptidyl polymer having three functional ends |
| BR112012022917A2 (pt) * | 2010-03-11 | 2017-01-10 | Pfizer | anticorpos com ligação a antígeno dependente de ph |
| AR081066A1 (es) * | 2010-04-02 | 2012-06-06 | Hanmi Holdings Co Ltd | Conjugado de insulina donde se usa un fragmento de inmunoglobulina |
| US8883134B2 (en) * | 2010-10-20 | 2014-11-11 | Handok Pharmaceuticals, Inc. | Human interleukin-1 receptor antagonist—hybrid Fc fusion protein |
| UA113626C2 (xx) * | 2011-06-02 | 2017-02-27 | Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії | |
| ES2692187T3 (es) | 2011-06-10 | 2018-11-30 | Hanmi Science Co., Ltd. | Nuevos derivados de oxintomodulina y composición farmacéutica para el tratamiento de obesidad que lo comprende |
| EP2721062B1 (en) * | 2011-06-17 | 2018-11-14 | Hanmi Science Co., Ltd. | A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
| BR112014005091A2 (pt) * | 2011-09-05 | 2017-06-13 | Beijing Hanmi Pharmaceutical Co Ltd | composição farmacêutica para o tratamento do câncer compreendendo conjugado de interferon alfa |
| KR20130049671A (ko) * | 2011-11-04 | 2013-05-14 | 한미사이언스 주식회사 | 생리활성 폴리펩타이드 결합체 제조 방법 |
| KR102041412B1 (ko) * | 2011-12-30 | 2019-11-11 | 한미사이언스 주식회사 | 면역글로불린 Ｆｃ 단편 유도체 |
-
2014
- 2014-07-11 AR ARP140102575A patent/AR096890A1/es unknown
- 2014-07-14 UA UAA201600304A patent/UA119644C2/uk unknown
- 2014-07-14 EP EP14822721.8A patent/EP3020732B1/en active Active
- 2014-07-14 CA CA2917838A patent/CA2917838C/en active Active
- 2014-07-14 CN CN202310310247.2A patent/CN116082528A/zh active Pending
- 2014-07-14 TW TW103124093A patent/TWI693236B/zh active
- 2014-07-14 PT PT148227218T patent/PT3020732T/pt unknown
- 2014-07-14 EA EA201690114A patent/EA034297B1/ru unknown
- 2014-07-14 WO PCT/KR2014/006328 patent/WO2015005747A1/ko active Application Filing
- 2014-07-14 CN CN201480049342.0A patent/CN105593243A/zh active Pending
- 2014-07-14 DK DK14822721.8T patent/DK3020732T3/da active
- 2014-07-14 JP JP2016525294A patent/JP2016525099A/ja active Pending
- 2014-07-14 MY MYPI2016000028A patent/MY180374A/en unknown
- 2014-07-14 KR KR1020140088530A patent/KR101872559B1/ko active Application Filing
- 2014-07-14 HU HUP1600206A patent/HU231424B1/hu unknown
- 2014-07-14 MX MX2016000344A patent/MX2016000344A/es active IP Right Grant
- 2014-07-14 US US14/904,543 patent/US20160152684A1/en not_active Abandoned
- 2014-07-14 ES ES14822721T patent/ES2799326T3/es active Active
- 2014-07-14 AU AU2014287879A patent/AU2014287879B2/en active Active
-
2016
- 2016-01-11 IL IL243567A patent/IL243567B/en active IP Right Grant
- 2016-01-12 PH PH12016500111A patent/PH12016500111A1/en unknown
- 2016-02-03 NO NO20160182A patent/NO20160182A1/en unknown
- 2016-08-23 HK HK16110033.0A patent/HK1221957A1/zh unknown
-
2018
- 2018-06-19 KR KR1020180070435A patent/KR102076718B1/ko active IP Right Grant
-
2020
- 2020-04-27 JP JP2020078005A patent/JP6880278B2/ja active Active
-
2022
- 2022-08-03 US US17/880,358 patent/US20220380437A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2021003I1 (lt) | Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su KIT | |
| DK3083694T3 (da) | Caniniserede, murine anti-canin-pd-1-antistoffer | |
| CL2016000257A1 (es) | Composiciones edulcorantes. | |
| DK2970449T3 (da) | Enkeltkædede bindingsmolekyler, der omfatter n-terminal abp | |
| CL2016000258A1 (es) | Composiciones edulcorantes. | |
| FR3006466B3 (fr) | . | |
| BR302014001378S1 (pt) | Configuração aplicada em bolsa. | |
| DK3242892T3 (da) | Modificerede april-bindende antistoffer | |
| BR112015024645A2 (pt) | composição de hidrocarboneto renovável | |
| BR302013002177S1 (pt) | Configuração aplicada em fusível. | |
| DK3020732T3 (da) | Immunoglobulin-Fc-konjugat, som bevarer immunoglobulin-Fc-fragmentets bindingsaffinitet til FcRn | |
| CL2016001147A1 (es) | Anticuerpos específicos para fcrn. | |
| DK2992104T3 (da) | Fremgangsmåde til ekspression | |
| DK2975030T3 (da) | Dihydropyridazin-3,5-dion-derivat | |
| DK2837678T3 (da) | Fremgangsmåde til forbedret afsmeltning | |
| DK3007725T3 (da) | Beta-glycolipider til anvendelse som adjuvanser | |
| CL2016001315A1 (es) | Separador. | |
| FR3001302B1 (fr) | . | |
| FR3003394B1 (fr) | Actionneur magnetothermique. | |
| CL2016000836A1 (es) | Composiciones de péptidos nuevas. | |
| FR3001303B1 (fr) | . | |
| ES1095555Y (es) | Criadero de caracoles. | |
| CL2015002282S1 (es) | Encendedor | |
| BR302013000310S1 (pt) | Configuração aplicada em refletor. | |
| BR302013000312S1 (pt) | Configuração aplicada em refletor. |